Nextplat Corp

NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3

NextPlat Regains Compliance with Nasdaq Bid Price Requirement

NextPlat's PharmcoRx Deploys Artificial Intelligence-Powered Prescription Processing Technology Supporting Expanded Nationwide Fulfillment Efforts

NextPlat's GTC Receives Satellite Enabled Internet of Things (IoT) Contracts Valued at $400,000 as its Government and Military Pipeline Surpasses $1.2 Million Through Q1 2026

NextPlat Announces 1-for-10 Reverse Stock Split to Be Effective Prior to Market Open on April 13, 2026